Name: Latest research reports of ICICI Prudential Asset Management Company Ltd. authored by SBI Securities and published by - Trendlyne research reports.
Item: ICICI Prudential Asset Management Company Ltd.
Rating: 3
Author: SBI Securities

ICICI Prudential Asset Management Company Ltd.

08 Dec 2025

2585.90

19.44%

ICICI Prudential Asset Management Company Limited IPO Note

IPO Note: ICICI Prudential Asset Man...

SBI Securities

ICICI Prudential Asset Management Company Ltd. (ICICIPru) is one of the oldest asset management companies (AMC) in India with a strong parentage of ICICI Bank and Prudential Corporation Holding Ltd. ICICIPru is also the largest AMC in India in terms of active mutual fund Quarterly Average Assets Under Management (QAAUM) and Equity & Equity-oriented QAAUM with a market share of 13.3% and 13.6% as of Sep'25, respectively. The total mutual fund QAAUM stood at Rs 10.1 tn as of same date which is second only to SBI MF. Equity and Equity-oriented schemes contribute ~56% of its total MF...

No SMAs available

Park Medi World Ltd.

08 Dec 2025

154.89

-0.30%

Park Medi World Ltd IPO Note

IPO Note: Park Medi World Ltd.

SBI Securities

Park Medi World Ltd. (PMWL) ranks as the second largest private hospital chain in North India with an aggregate bed capacity of 3,000 beds as of FY25. PMWL operates a network of 14 NABH accredited multi-super specialty hospitals under the Park' brand. It offers over 30 super specialty and specialty services including internal medicine, neurology, urology, gastroentereology general surgery, orthopedics and oncology. As of Sep'25, PMWL had a dedicated team of 1,014...

HDFC Securities released a IPO Note report for Park Medi World Ltd. on 10 Dec, 2025.

Nephrocare Health Services Ltd.

08 Dec 2025

449.15

-2.72%

Nephrocare Health Services Ltd IPO Note

IPO Subscribe: Nephrocare Health Services...

SBI Securities

Nephrocare Health Services Ltd. (NHSL) is a dialysis services provider which offers comprehensive dialysis care through its network of clinics from diagnosis to treatment and wellness programs including haemodialysis, home and mobile dialysis, supported by pharmacy. In FY25, the company served 29,281 patients and completed 28,85,450 treatments in India which represented ~10% of the total dialysis patients in India. NHSL is India's only dialysis services provider with an international presence having a network of 51 clinics across the Philippines, Uzbekistan and Nepal as of Sep'25. The...

No SMAs available

Medi Assist Healthcare Services Ltd.

08 Dec 2025

437.00

0.02%

Medi Assist Healthcare Services Ltd

Buy: Medi Assist Healthcare Ser...

Keynote Capitals Ltd

Initiating Coverage Report

Institutional Investors have increased holdings from 56.19% to 71.90% in Sep 2025 qtr.

Biocon Ltd.

08 Dec 2025

398.55

1.61%

Integration to bring scale and clarity

Buy: Biocon Ltd.

Target

Motilal Oswal

Biocon (BIOS) is fully integrating Biocon Biologics (BBL) by acquiring the remaining stake of 23.3%. In addition to the share swap, BIOS is raising additional capital through a QIP of up to INR45b, subject to shareholder approval, for the cash component payable to Viatris.

Biocon Ltd. is trading above all available SMAs

Suzlon Energy Ltd.

08 Dec 2025

52.59

1.56%

Engineering the Wind Rebound

Buy: Suzlon Energy Ltd.

Anand Rathi

Suzlon is well-placed to capitalise on India’s growing wind cycle, supported by substantial scale leverage at its Puducherry plant (~30% utilisation with the ability to ramp from 3 to 8 nacelles/day) with minimal capex, while the addition of three AI-enabled blade facilities would enhance logistics and execution.

Anand Rathi released a Buy report for Suzlon Energy Ltd. with a price target of 82.0 on 08 Dec, 2025.

SRF Ltd.

08 Dec 2025

3090.30

1.30%

Upcycle across chemicals businesses; upside risk to consensus EPS

Buy: SRF Ltd.

Recommendation Target

ICICI Securities Limited

We remain sanguine on SRF’s chemicals business, with performance potentially improving across ref-gas, specialty chemicals and fluoropolymers. Higher volumes and sustained prices present ~15–20% upside risk in ref-gas business’ base-case revenues vs. a more plausible assessment.

Number of FII/FPI investors increased from 670 to 679 in Sep 2025 qtr.

RBL Bank Ltd.

08 Dec 2025

300.25

0.50%

CXO 1x1: R. Subramaniakumar, MD & CEO

Buy: RBL Bank Ltd.

ICICI Securities Limited

Our meeting with RBL Bank’s (RBL) MD&CEO further cements our positive stance on RBL. We believe the proposed USD 3bn capital infusion (link) from Emirates NBD (ENBD) catapults RBL several notches up in terms of net worth, CET1, technology offering, funding competitiveness and distribution, thereby securing huge growth runway.

RBL Bank has gained 31.67% in the last 6 Months

Bharat Heavy Electricals Ltd.

08 Dec 2025

275.75

0.25%

The fundamentals are improving…

Buy: Bharat Heavy Electricals Ltd.

Target

ICICI Securities Limited

BHEL has accumulated a strong orderbook in last three years but execution has been slow. Order inflow (OI) in FY24/25 was INR 780bn/ INR 920bn (vs. average OI of INR 210bn between FY19-23), respectively.

ICICI Securities Limited increased Buy price target of Bharat Heavy Electricals Ltd. to 370.0 on 08 Dec, 2025.

Nifty 50

08 Dec 2025

25966.40

0.58%

Sectoral Derivative Snapshot

Nifty 50

SBI Securities

Retail Research

Nifty 50's price crossed above 50Day SMA today